RNF213 and neoplasm: The results showed that there were differences in the protein expression of RNF213 in different clinical stages (p = 0.011) and pathological N (p = 0.02) in the Chinese-LUAD study data, and the higher the level of clinical stage, the wider the scope of tumor metastasis, corresponding the higher expression of RNF213 (Figure 2C,D).